Example: Heart Attack

Clinical Trials on Polycystic Kidney Diseases

Total 145 results

NCT03423810

Completed

Assessing a Dose-Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients

Conditions: Polycystic Kidney Diseases
NCT02558595

Completed

Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)

Conditions: Polycystic Kidney Disease
NCT04284657

Recruiting

Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT03948113

Completed

Outcome of Autosomal Dominant Polycystic Kidney Disease Patients on Peritoneal Dialysis: a National Retrospective Study Based on Two French Registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).

Conditions: Polycystic Kidney Diseases
NCT02140814

Completed

Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease

Conditions: Polycystic Kidney Disease
NCT00792155

Recruiting

Polycystic Kidney Disease Data Repository

Conditions: Polycystic Kidney Disease
NCT02933268

Completed

High Water Intake in Polycystic Kidney Disease

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT02127437

Completed

Lanreotide In Polycystic Kidney Disease Study

Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD
NCT01988038

Withdrawn

Repository Study of Autosomal Dominant Polycystic Kidney Disease

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT04064346

Not yet recruiting

Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease

Conditions: Polycystic Kidney Disease, Adult
NCT04152837

Recruiting

Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease

Conditions: Polycystic Kidney Disease, Adult
NCT04786574

Not yet recruiting

A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Conditions: Autosomal Recessive Polycystic Kidney Disease (ARPKD)
NCT03901521

Active, not recruiting

Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT02697617

Completed

Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease

Conditions: Polycystic Kidney Disease
NCT01039987

Completed

Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT04344769

Recruiting

Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT04536688

Recruiting

A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease

Conditions: Polycystic Kidney Disease, Autosomal Dominant
NCT04578548

Recruiting

A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT00286156

Completed

Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Conditions: Polycystic Kidney Diseases
NCT03487913

Completed

The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT01451827

Completed

8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT02134899

Completed

The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT01377246

Completed

Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT00414440

Completed

Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT02964273

Active, not recruiting

Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)